D.E. Shaw & Co’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-12,225
| Closed | -$46K | – | 2932 |
|
|
2020
Q1 | $46K | Sell |
12,225
-22,209
| -64% | -$83.6K | ﹤0.01% | 2598 |
|
|
2019
Q4 | $175K | Buy |
+34,434
| New | +$175K | ﹤0.01% | 2530 |
|
|
2016
Q2 | – | Sell |
-11,552
| Closed | -$50K | – | 2754 |
|
|
2016
Q1 | $50K | Sell |
11,552
-2,707
| -19% | -$11.7K | ﹤0.01% | 2528 |
|
|
2015
Q4 | $87K | Sell |
14,259
-2,041
| -13% | -$12.5K | ﹤0.01% | 2540 |
|
|
2015
Q3 | $93K | Sell |
16,300
-3,196
| -16% | -$18.2K | ﹤0.01% | 2457 |
|
|
2015
Q2 | $145K | Sell |
19,496
-55,238
| -74% | -$411K | ﹤0.01% | 2510 |
|
|
2015
Q1 | $447K | Sell |
74,734
-141,901
| -66% | -$849K | ﹤0.01% | 2107 |
|
|
2014
Q4 | $1.64M | Buy |
216,635
+155,022
| +252% | +$1.17M | ﹤0.01% | 1449 |
|
|
2014
Q3 | $320K | Buy |
+61,613
| New | +$320K | ﹤0.01% | 2023 |
|
|
2014
Q2 | – | Sell |
-11,689
| Closed | -$48K | – | 2661 |
|
|
2014
Q1 | $48K | Sell |
11,689
-395,074
| -97% | -$1.62M | ﹤0.01% | 2265 |
|
|
2013
Q4 | $2.17M | Sell |
406,763
-168,331
| -29% | -$897K | ﹤0.01% | 1260 |
|
|
2013
Q3 | $2.89M | Buy |
575,094
+71,001
| +14% | +$357K | ﹤0.01% | 1095 |
|
|
2013
Q2 | $2.25M | Buy |
+504,093
| New | +$2.25M | ﹤0.01% | 1137 |
|